To the end of chronic lymphocytic leukemia: what should be the role of allogeneic transplant?

In this article the authors discuss the role of allogeneic transplantation in the treatment of chronic lymphocytic leukemia (CLL) and the article "Low Tumor Burden Is Associated With Early B-Cell Reconstitution and Is a Predictor of Favorable Outcome After Non-Myeloablative Stem Cell Transplant for Chronic Lymphocytic Leukemia" by K. Hebenstreit, S. Iacobelli, S. Leiblein et al. within the issue. They are supportive of using the drugs idelalisib and ibrutinib to treat CLL and of only using allogenic transplantation in patients who do not respond to the drugs.